Ajanta Pharmaceuticals SUMMARY
Ajanta Pharmaceuticals is trading -0.70% lower at Rs 1,776.85 as compared to its last closing price. Ajanta Pharmaceuticals has been trading in the price range of 1,793.40 & 1,776.85. Ajanta Pharmaceuticals has given 49.14% in this year & 6.57% in the last 5 days.
Ajanta Pharmaceuticals has TTM P/E ratio 30.05 as compared to the sector P/E of 21.97.
The company posted a net profit of 208.12 Crores in its last quarter.
Listed peers of Ajanta Pharmaceuticals include IPCA Laboratories (-0.88%), JB Chemicals & Pharmaceuticals (0.01%), Ajanta Pharmaceuticals (-0.70%) etc.
FAQs about Ajanta Pharmaceuticals share price
Ajanta Pharmaceuticals is trading at 1776.85 as on Wed Oct 04 2023 06:02:43. This is -0.70% lower as compared to its previous closing price of 1789.40.
The market capitalization of Ajanta Pharmaceuticals is 22373.32 Cr as on Wed Oct 04 2023 06:02:43.
The 52 wk high for Ajanta Pharmaceuticals is 1903.85 whereas the 52 wk low is 1105.46
Ajanta Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 30.05
- Sector P/E: 21.97
- Dividend Yield: 0.95%
- D/E ratio: -
Ajanta Pharmaceuticals reported a net profit of 587.98 Cr in 2023.
Ajanta Pharmaceuticals Quick Links
Ajanta Pharmaceuticals Dividend | Ajanta Pharmaceuticals Bonus | Ajanta Pharmaceuticals News | Ajanta Pharmaceuticals AGM | Ajanta Pharmaceuticals Rights | Ajanta Pharmaceuticals Splits | Ajanta Pharmaceuticals Board Meetings | Ajanta Pharmaceuticals Key Metrics | Ajanta Pharmaceuticals Shareholdings | Ajanta Pharmaceuticals Profit Loss | Ajanta Pharmaceuticals Balance Sheet | Ajanta Pharmaceuticals Cashflow | Ajanta Pharmaceuticals Q1 Results | Ajanta Pharmaceuticals Q2 Results | Ajanta Pharmaceuticals Q3 Results | Ajanta Pharmaceuticals Q4 Results
Equity Quick Links
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks